REDWOOD CITY, Calif. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Kriya announced the expansion of its gene therapy pipeline and its rare disease therapeutic area division with the acquisition of Warden Bio.
Author: Business Wire
Cellusion Raises 1.1B JPY to Advance Japan and Global Clinical Trials of CLS001 for Corneal Endothelial Cell Regenerative Therapy
TOKYO–(BUSINESS WIRE)– #Asia–Cellusion Inc., a regenerative medicine startup aiming to solve the global Corneal transplant waiting list problem with a unique differentiation induction method from iPS cells to Corneal Endothelial Cell Substitute from…
Retina Institute of Washington Enters Partnership with Comprehensive EyeCare Partners
LAS VEGAS & SEATTLE–(BUSINESS WIRE)– #CompEye–Comprehensive EyeCare Partners (CompEye), one of the largest vision care practice management organizations in the nation, is pleased to announce a strategic partnership with Retina Institute of Washingto…
Glaukos Announces FDA 510(k) Clearance of iPRIME™
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that …
The Beekman Group Partners with Campus Eye to Accelerate Growth
NEW YORK–(BUSINESS WIRE)–The Beekman Group is pleased to announce that an affiliate of Beekman Investment Partners IV (“Beekman”) has formed a strategic partnership with Campus Eye Group of Hamilton, NJ and Total Eye Care (“TECC”) of Levittown, PA, c…
Global Sports Optic Market (2021 to 2026) – Enhanced Fan Participation is Propelling Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Sports Optic Market (2021-2026) by Product, Price Range, Distribution Channel, Games, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets….
Melinta Therapeutics President and CEO Christine Ann Miller Elected to Board of Directors of Iveric Bio
MORRISTOWN, N.J.–(BUSINESS WIRE)–Melinta Therapeutics, LLC (“Melinta”), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, announced today that President and Chief Executive Officer Christine Ann Mille…
Sonoma Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference January 10-13, 2022
WOODSTOCK, Ga.–(BUSINESS WIRE)–Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care,…
Nationally Recognized Ophthalmologist Dr. Elizabeth Yeu Joins Avellino’s Board of Directors
MENLO PARK, Calif.–(BUSINESS WIRE)– #AvaGen–Nationally recognized ophthalmologist Dr. Elizabeth Yeu joins the Board of Directors for Avellino Lab USA, Inc.
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK–(BUSINESS WIRE)–Iveric Bio granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to eight newly-hired, non-executive employees.
Worldwide Spectacle Lens Industry to 2028 – by Type, Application, End Users, Countries and Companies – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Spectacle Lens Market Growth Analysis and Insights, 2021: Trends, Market Size, Share Outlook and Opportunities by Type, Application, End Users, Countries and Companies to 2028” report has been added to ResearchAndMarkets.c…
Midwest Vision Partners Announces Partnership With Retina Consultants of Michigan
CHICAGO & SOUTHFIELD, Mich.–(BUSINESS WIRE)–Midwest Vision Partners (“MVP”) is excited to announce its partnership with Retina Consultants of Michigan (“RCM”). This represents MVP’s eighteenth partnership, broadening its network to over 125 providers…
EyeSouth Partners Completes its 27th Affiliation Through Partnership with Clayton Eye Center
ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has completed an affiliation with Clayton Eye Center (“CEC”). The affiliation represents EyeSouth’s eleventh in the state of Georgia and twenty-sev…
Mojo Vision Partners With Fitness Brands to Elevate Sports and Fitness Experience and Performance via Its Smart Contact Lens
SARATOGA, Calif.–(BUSINESS WIRE)–Mojo Vision, the Invisible Computing Company, today announced strategic partnerships with leading sports and fitness brands to collaborate on next-generation user experiences that combine augmented reality, wearable t…
Ocular Therapeutix™ to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (Nasdaq: OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
Lineage Cell Therapeutics to Present at H.C. Wainwright Bioconnect Virtual Conference
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that B…
Ray Therapeutics Closes $6M Seed Financing to Advance Novel Optogenetics Platform to Treat Blinding Diseases
SAN DIEGO–(BUSINESS WIRE)– #genetic–Ray Therapeutics Closes $6M Seed Financing to Advance Novel Optogenetics Platform to Treat Blinding Diseases.
Aldeyra Therapeutics Completes Enrollment in Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company discovering and developing innovative therapies for the treatment of immune-mediated diseases, today announced completion of enrollment in P…
Iveric Bio to Present at the H.C. Wainwright BioConnect Virtual Conference
NEW YORK–(BUSINESS WIRE)–Iveric Bio will participate in the H.C. Wainwright BioConnect Virtual Conference, being held virtually from January 10-13, 2022.
NovaBay Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company focused on developing and commercializing scientifically formulated and clinically proven consumer products for the eyecare and skincare …